How to Write a NEJM Cover Letter (With Template)

NEJM desk-rejects more than 80% of manuscripts within 7 days. Most of those rejections happen before a single external reviewer reads the paper. The cover letter doesn't save a weak paper, but a weak cover letter can sink a strong one.

The NEJM cover letter has a specific job. It has to make the case for why this finding belongs in the most read medical journal in the world, in 300-400 words, before an editor decides whether to spend more time with your manuscript.

What NEJM Editors Are Looking For

NEJM publishes clinical medicine with immediate practice implications. The cover letter has to answer two questions convincingly: what did you find, and why does it change what physicians do?

Those questions sound simple. Most cover letters fail at least one of them.

"What did you find" requires a specific claim, not a description of your study. "We found that X was associated with Y" is a description. "X reduces mortality in patients with Z by 22% compared to standard care, based on a prespecified primary endpoint in our multicenter RCT" is a finding.

"Why does it change practice" requires naming the practice that changes. Not "this has important implications for patient care." Which patients, which treatment decision, which guideline, which clinical pathway?

The Three Things a NEJM Cover Letter Must Do

1. State the clinical finding in one sentence. Active voice. Specific number. Named outcome. "In a randomized trial of 4,200 patients with [condition], [intervention] reduced [outcome] by [magnitude] compared to [comparator]."

2. State the practice implication. "Current guidelines recommend [current standard]. Our findings provide definitive evidence that [change], which would affect [estimated number/population] of patients annually."

3. Confirm study integrity. Registration number. Funding source. Brief data safety monitoring board note if applicable. This signals you understand what NEJM cares about before the paper is even opened.

NEJM Cover Letter Template

Dear Editors,
[One sentence: clinical finding with specific data point and named outcome.]
[One to two sentences: practice implication. What changes in how physicians treat patients, and how many patients are affected?]
[One sentence: study design summary for context. Multicenter? RCT? Registry? N=?]
[One sentence: registration and funding. "This trial is registered at ClinicalTrials.gov (NCT[number]) and was funded by [source]."]
[Optional: one sentence on statistical analysis plan if pre-specified and this is an efficacy trial.]
We confirm that this manuscript has not been published and is not under consideration elsewhere. [Preprint disclosure if applicable.]
Sincerely,
[Corresponding author, institution]

Two Cover Letter Openings That Work

Opening 1 (RCT): "In a multicenter randomized trial of 3,800 patients with heart failure with reduced ejection fraction, finerenone reduced the composite of cardiovascular death and worsening heart failure by 18% compared to placebo, with consistent effects across prespecified subgroups including patients already receiving SGLT2 inhibitors."

Why it works: specific intervention, specific population, specific outcome, specific magnitude, specific comparison, scope of evidence addressed in one sentence.

Opening 2 (Observational/epidemiological): "Among 1.4 million adults in a nationwide registry, patients with type 2 diabetes who initiated GLP-1 receptor agonists had a 27% lower rate of major adverse cardiovascular events over 5 years compared to those initiating DPP-4 inhibitors, after adjustment for 47 prespecified confounders."

Why it works: scale, comparison defined, outcome defined, magnitude stated, analytic rigor signaled briefly.

What to Cut

Journal praise. "NEJM is the premier medical journal and we believe this work is ideally suited for its readership." Cut. Entirely.

Methods details. The cover letter isn't the methods section. If your design is clean, one sentence is enough. If you use two paragraphs on statistical analysis plan in the cover letter, you've lost the plot.

Implications that aren't implications. "This work has significant implications for future research in this area." That's not a practice implication. That's a sentence that says nothing.

Hedged findings. "Our results suggest that X may potentially play a role in Y." If you can't claim your finding, NEJM can't publish it.

NEJM Presubmission Inquiries

NEJM accepts presubmission inquiries for papers where fit is uncertain. Format: 200-word summary of study design, primary finding, and clinical significance. Response within 2-5 business days.

Worth doing for unusually designed studies, negative trials, or work where you're genuinely unsure whether it meets the NEJM clinical-significance bar. Not worth doing when the fit is clear, positive or negative.

What NEJM Requires That Others Don't

Prior registration for trials. NEJM requires trial registration before enrollment begins, not before submission. Post-enrollment registration is a rejection trigger for RCTs.

Preprint disclosure. If you've posted to medRxiv or SSRN, disclose it explicitly. Don't hope they won't find it.

Data availability statement. Where is the data? Who can access it and under what conditions? This needs to be in the cover letter and the paper.

Authorship contribution statement. Every author's contribution must be specified. Corresponding author confirms all contributors meet ICMJE criteria.

The Length Rule

300-400 words. Not more. NEJM editors read many cover letters. A letter that makes its case in 350 words demonstrates that you know what your key points are. A 700-word letter that meanders suggests you don't.

Adapting for Specific Study Types

For randomized controlled trials: Your cover letter should explicitly note the CONSORT checklist is included, the ClinicalTrials.gov registration number, and your DSMB (if applicable). NEJM editors want to see these signals immediately.

For large observational studies: Note the analytic approach briefly (retrospective cohort, case-control, propensity-matched), the data source (national registry, EMR system, specific cohort), and the N. NEJM is skeptical of observational studies for practice-changing claims; your letter needs to preempt this by acknowledging limitations and explaining why the finding is still actionable.

For basic/translational work: NEJM is almost never the right venue for non-clinical work. If you believe you have an exception, the cover letter burden of proof is very high. The clinical relevance has to be direct and immediate.

For negative trials: NEJM has published landmark negative trials (ACCORD, HEAT, ARISE). If your trial is negative, definitively negative with adequate power, your cover letter should lead with the negative result and explain why it definitively settles the clinical question. "We failed to show X" is not a cover letter opening. "Our adequately powered trial definitively establishes that X doesn't reduce Y in population Z, settling a decade-long clinical debate" is.

The Corresponding Author's Role at NEJM

NEJM requires the corresponding author to confirm that all authors meet ICMJE authorship criteria, that no one who qualifies as an author has been omitted, and that the manuscript is not under consideration elsewhere. These are standard, but NEJM is stricter about checking them than most journals.

The corresponding author is also the point of contact for all editorial communications. If your trial has a steering committee chair or a principal investigator who is different from the submitting corresponding author, note that clearly on the title page and in the cover letter.

Post-Acceptance at NEJM

After acceptance, NEJM goes through a thorough production process. Expect:

• Copyediting that may substantially restructure sentences (NEJM's house style is distinct)
• Author queries on any claims that need citation support
• Final author proofing before publication
• Embargo coordination if the paper is releasing alongside a conference presentation

Total post-acceptance to publication: typically 4-8 weeks for standard articles. Articles tied to major conference presentations are often fast-tracked.

One-Page Constraint Is a Feature

NEJM cover letters should fit on one page because editorial time is limited. The constraint forces prioritization: finding, practice impact, and integrity signal. If your letter needs two pages, your argument is not focused enough yet.

Final Pre-Submit Check

• Specific result with magnitude in first sentence
• Practice implication in second paragraph
• Trial registration and disclosures included
• No journal flattery, no methods dump

Keep It Clinical

NEJM letters fail when they sound academic instead of clinical. If your language doesn't map to patient decisions, it reads as out of scope. Keep every paragraph anchored to clinical consequence.

The Bottom Line

A strong NEJM cover letter states a specific clinical finding, identifies the specific practice change, confirms study integrity in one sentence, and stops. Everything else is noise. The paper has to carry the science; the cover letter has to make the case for why NEJM should spend time on it.

Sources

• NEJM author center: nejm.org/author-center
• ICMJE author guidelines: icmje.org/recommendations
• Is NEJM a good journal?
• NEJM submission guide

See also

• NEJM journal overview
• Is NEJM a good journal?
• JAMA cover letter guide
• How to write a journal cover letter